Lawmakers Ask Gilead to Justify ‘Extraordinarily High’ Cost of Sovaldi

Drug Industry Daily
A A
House Democrats are asking Gilead Sciences to justify the cost of its pricy hepatitis C pill Sovaldi, saying many of their constituents affected by the disease may not be able to afford it.

To View This Article:

Login

Subscribe To Drug Industry Daily